Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : ORCA-010
Therapeutic Area : Oncology
Study Phase : Phase I/ Phase II
Sponsor : CMX Research
Deal Size : Inapplicable
Deal Type : Inapplicable
Orca Therapeutics to Start Highest Dose in Treatment-Naïve Prostate Cancer
Details : The independent DSMB unanimously recommended the continuation of the study without modification. From this recommendation, ORCA Therapeutics will initiate administration of the highest scheduled dose level of ORCA-010 in the single dose part of the study...
Product Name : Undisclosed
Product Type : Microorganism
Upfront Cash : Inapplicable
May 03, 2021
Lead Product(s) : ORCA-010
Therapeutic Area : Oncology
Highest Development Status : Phase I/ Phase II
Sponsor : CMX Research
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : ORCA-010
Therapeutic Area : Oncology
Study Phase : Phase I/ Phase II
Sponsor : CMX Research
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Microorganism
Upfront Cash : Inapplicable
September 20, 2019
Lead Product(s) : ORCA-010
Therapeutic Area : Oncology
Highest Development Status : Phase I/ Phase II
Sponsor : CMX Research
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
